IL-6 INCREASES ENDOTHELIAL PERMEABILITY INVITRO

被引:366
作者
MARUO, N [1 ]
MORITA, I [1 ]
SHIRAO, M [1 ]
MUROTA, SI [1 ]
机构
[1] TOKYO MED & DENT UNIV,FAC DENT,PHYSIOL CHEM SECT,1-5-45 YUSHIMA,BUNKYO KU,TOKYO 113,JAPAN
关键词
D O I
10.1210/en.131.2.710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of interleukin 6 (IL-6) on endothelial permeability was examined by measuring fluorescein isothiocyanate-labeled albumin flux across an endothelial cell monolayer. Bovine vascular endothelial cells (BVEC) were cultured up to confluency on collagen-coated polycarbonate micropore filters and then the filters were mounted on modified Boyden chambers. Treatment of the BVEC with IL-6 at 100 ng/ml for 21 h caused a remarkable increase in the permeability of fluorescein isothiocyanate-labeled albumin across the endothelial monolayer. This effect of IL-6 was concentration dependent, in the range from 10-200 ng/ml of IL-6. The effect of IL-6 was also time dependent, the maximal level being reached at 21 h from the beginning of the treatment. This stimulatory effect of IL-6 on albumin clearance was completely abolished by the addition of anti-IL-6 antibody. Light microscopic observation of a cross-section of a monolayer showed that the IL-6-induced increase in the permeability was correlated with changes in cell shape and rearrangement of intracellular actin fibers. IL-6 did not show any cytotoxicity toward or growth inhibition of endothelial cells, even at more than 200 ng/ml. The enhancing effect of IL-6 on the increase in the permeability was reversible; when IL-6 was removed by a medium change and the cells were incubated for a further 24 h without IL-6, the permeability was restored to the control level. These results suggest that IL-6 can induce an increase in endothelial permeability in vitro by rearranging actin filaments and by changing the shape of endothelial cell.
引用
收藏
页码:710 / 714
页数:5
相关论文
共 17 条
[1]   CAPILLARIES OF THE ADRENAL-CORTEX POSSESS AMINOPEPTIDASE A AND ANGIOTENSIN-CONVERTING ENZYME-ACTIVITIES [J].
DELVECCHIO, PJ ;
RYAN, JW ;
CHUNG, A ;
RYAN, US .
BIOCHEMICAL JOURNAL, 1980, 186 (02) :605-608
[2]   PURIFICATION TO HOMOGENEITY AND CHARACTERIZATION OF HUMAN B-CELL DIFFERENTIATION FACTOR (BCDF OR BSFP-2) [J].
HIRANO, T ;
TAGA, T ;
NAKANO, N ;
YASUKAWA, K ;
KASHIWAMURA, S ;
SHIMIZU, K ;
NAKAJIMA, K ;
PYUN, KH ;
KISHIMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) :5490-5494
[3]   EXCESSIVE PRODUCTION OF INTERLEUKIN-6/B CELL STIMULATORY FACTOR-II IN RHEUMATOID-ARTHRITIS [J].
HIRANO, T ;
MATSUDA, T ;
TURNER, M ;
MIYASAKA, N ;
BUCHAN, G ;
TANG, B ;
SATO, K ;
SHIMIZU, M ;
MAINI, R ;
FELDMAN, M ;
KISHIMOTO, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (11) :1797-1801
[4]  
JIRIK FR, 1989, J IMMUNOL, V142, P144
[5]  
KILLACKEY JJF, 1986, AM J PATHOL, V122, P50
[6]   THE BIOLOGY OF INTERLEUKIN-6 [J].
KISHIMOTO, T .
BLOOD, 1989, 74 (01) :1-10
[7]   INHIBITORY EFFECTS OF INTERLEUKIN 6 ON PROSTAGLANDIN I2 PRODUCTION IN CULTURED BOVINE VASCULAR ENDOTHELIAL-CELLS [J].
MARUO, N ;
MORITA, I ;
ISHIZAKI, Y ;
MUROTA, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 292 (02) :600-604
[8]   ESTABLISHMENT OF AN INTERLEUKIN 6 (IL 6)/B-CELL STIMULATORY FACTOR 2-DEPENDENT CELL-LINE AND PREPARATION OF ANTI-IL-6 MONOCLONAL-ANTIBODIES [J].
MATSUDA, T ;
HIRANO, T ;
KISHIMOTO, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (06) :951-956
[9]   ISOPROTERENOL REDUCES THROMBIN-INDUCED PULMONARY ENDOTHELIAL PERMEABILITY INVITRO [J].
MINNEAR, FL ;
DEMICHELE, MAA ;
MOON, DG ;
RIEDER, CL ;
FENTON, JW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :H1613-H1623
[10]  
MORITA I, 1984, BIOCHIM BIOPHYS ACTA, V792, P304